UCLA's Jonsson Comprehensive Cancer Center : JCCC Member Directory

Francis Charles Brunicardi, M.D., F.A.C.S.

Specialty:

General surgery

General Information:

Gender:	Male
Language(s):	English

Affiliation(s):

Professor and Chief, Department of Surgery, General Surgery

Member, JCCC Signal Transduction and Therapeutics Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Santa Monica-UCLA Medical Center and Orthopaedic Hospital

Education:

Fellowship:	Surgery, SUNY Downstate Medical Center College of Medicine, 1983 - 1986
Residency:	Surgery, SUNY Downstate Medical Center College of Medicine, 1986 - 1989 Surgery, SUNY Downstate Medical Center College of Medicine, 1982 - 1983
Internship:	Surgery, UCSF/Mount Zion Medical Center, 1981 - 1982
Medical Degree:	M.D., UMDNJ New Jersey Medical School, 1980

Certification(s):

Medical Board Certification(s):	Surgery, American Board of Surgery, 1990, 1998, 2009

Contact Information:

Phone:	(310) 562-1635
Email:	cbrunicardi@mednet.ucla.edu
Website:	http://www.surgery.ucla.edu

Practice Information:

Clinical Interest(s):	General surgery Gastrointestinal cancers Neuroendocrine tumors

Scientific Interest(s):

Dr. Charles Brunicardi's research interests are in pancreas cancer, RNAi therapy for cancer, gene therapy for cancer, islet physiology and personalized medicine.

Selected Cancer-Related Publications:

Liu S, Rao D, Nemunaitis J, Senzer N, Dawson D, Gingras M, Wang Z, Gibbs R, Norman M, Templeton N, DeMayo F, Stehling K, Fisher W, Brunicardi C. A novel therapeutic strategy for pancreatic neoplasia using a novel RNAi platform targeting PDX-1. Nature Precedings, June 2011

Brunicardi FC, Gibbs RA, Wheeler DA, Nemunaitis J, Fisher W, Goss J, Chen C. Overview of the development of personalized genomic medicine and surgery. World J Surg. 2011 Aug;35(8):1693-9.

Liu SH, Patel S, Gingras MC, Nemunaitis J, Zhou G, Chen C, Li M, Fisher W, Gibbs R, Brunicardi FC. PDX-1: demonstration of oncogenic properties in pancreatic cancer. Cancer. 2011 Feb 15;117(4):723-33. doi: 10.1002/cncr.25629. Epub 2010 Sep 30.

Liang YY, Brunicardi FC, Lin X. Smad3 mediates immediate early induction of Id1 by TGF-beta. Cell Res. 2009 Jan;19(1):140-8.

Liu S, Ballian N, Belaguli NS, Patel S, Li M, Templeton NS, Gingras MC, Gibbs R, Fisher W, Brunicardi FC. PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas. 2008 Aug;37(2):210-20.